Eli Lilly and Company
LLYLast close · Oct 16, 20261,257.03+5.42 (+0.43%)
Market cap$1.2T
Of the 85 managers this site tracks, 10 held Eli Lilly (LLY) at the end of Q3 2026, their latest 13Fs. The largest position by value was Polen Capital's, $799.9M; Mairs & Power's ($386.4M) and Jensen's ($184.4M) follow. No Schedule 13D or 13G is on file for LLY from the activists and large holders the site follows.
Superinvestors holding LLY
| Manager | Firm | Quarter | Shares | Value |
|---|---|---|---|---|
| Polen Capital | Polen Capital Management LLC | Q2 2026 | 666,912 | $799.9M |
| Mairs & Power | Mairs & Power Inc | Q2 2026 | 322,129 | $386.4M |
| Jensen | Jensen Investment Management Inc | Q2 2026 | 153,735 | $184.4M |
| Bridgewater | Bridgewater Associates, LP | Q2 2026 | 87,023 | $104.4M |
| Dodge & Cox | Dodge & Cox | Q2 2026 | 41,258 | $49.5M |
| Soros | Soros Fund Management LLC | Q2 2026 | 22,199 | $26.6M |
| Druckenmiller | Duquesne Family Office LLC | Q2 2026 | 12,380 | $14.8M |
| Bill Nygren | Harris Associates L P | Q2 2026 | 431 | $516,954 |
| Torray | Torray Investment Partners LLC | Q2 2026 | 398 | $477,373 |
| David Katz | Matrix Asset Advisors Inc | Q3 2026 | 305 | $352,453 |
13D/13G are SEC beneficial-ownership disclosures, triggered only above 5%; a 13F is a quarterly snapshot filed up to 45 days after quarter end. Superinvestor names link to their full portfolios under Investors.